Literature DB >> 21743329

Mental capacity and consent to treatment in psychiatric patients: the state of the research.

Paola C Candia1, Alfredo C Barba.   

Abstract

PURPOSE OF REVIEW: The past three decades have seen the emergence of the field of decision-making capacity research. The growth has been such that there are several reviews covering a variety of subtopics within the field. The goal is to briefly summarize the state of research. RECENT
FINDINGS: Most studies in this field use the MacArthur Competence Assessment Tools for the decisional capacity assessment. Studies in psychiatric patients indicate incapacity is common (20-30%), but the majority are capable of making treatment decisions. Positive symptoms (hallucinations, delusions); negative symptoms (unusual thought content, conceptual disorganization); severity of symptoms; involuntary admission; lack of insight and treatment refusal were the stronger predictors for incapacity in acute and cognitive dysfunction in chronic patients.
SUMMARY: Mental capacity has complex relationships with psychopathological variables, and these relationships are different according to diagnostic group. More research is needed to determine the clinical parameters related to the lack of capacity to make treatment decisions in psychiatric patients.

Entities:  

Mesh:

Year:  2011        PMID: 21743329     DOI: 10.1097/YCO.0b013e328349bba5

Source DB:  PubMed          Journal:  Curr Opin Psychiatry        ISSN: 0951-7367            Impact factor:   4.741


  10 in total

1.  Treatment decision-making capacity in non-consensual psychiatric treatment: a multicentre study.

Authors:  G Mandarelli; F Carabellese; G Parmigiani; F Bernardini; L Pauselli; R Quartesan; R Catanesi; S Ferracuti
Journal:  Epidemiol Psychiatr Sci       Date:  2017-03-09       Impact factor: 6.892

2.  Assessment of shared decision-making in community mental health care: Validation of the CollaboRATE.

Authors:  Carlos De Las Cuevas; Ingunn Mundal; Moisés Betancort; Mariela L Lara-Cabrera
Journal:  Int J Clin Health Psychol       Date:  2020-08-01

3.  "For Their Own Good": A Response to Popular Arguments Against Permitting Medical Assistance in Dying (MAID) where Mental Illness Is the Sole Underlying Condition.

Authors:  Justine Dembo; Udo Schuklenk; Jonathan Reggler
Journal:  Can J Psychiatry       Date:  2018-04-10       Impact factor: 4.356

4.  Customising informed consent procedures for people with schizophrenia in India.

Authors:  Sudipto Chatterjee; Berit Kieselbach; Smita Naik; Shuba Kumar; Sujit John; Madhumitha Balaji; Mirja Koschorke; Hamid Dabholkar; Mathew Varghese; Vikram Patel; Graham Thornicroft; Rangaswamy Thara
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2015-03-04       Impact factor: 4.328

5.  Publication Ethics.

Authors:  Pramod Kumar Singh; Vinay Kumar; Shahul Ameen; Sujit Sarkhel; Samir Kumar Praharaj; Vikas Menon
Journal:  Indian J Psychiatry       Date:  2022-03-22       Impact factor: 1.759

Review 6.  Ethics in Psychiatric Research: Issues and Recommendations.

Authors:  Shobhit Jain; Pooja Patnaik Kuppili; Raman Deep Pattanayak; Rajesh Sagar
Journal:  Indian J Psychol Med       Date:  2017 Sep-Oct

7.  The recovery of factors associated with decision-making capacity in individuals with psychosis.

Authors:  Colin Fernandez; Harry G Kennedy; Miriam Kennedy
Journal:  BJPsych Open       Date:  2017-05-04

Review 8.  End-of-Life Care in Individuals With Serious Mental Illness.

Authors:  Daniel Shalev; Lauren Fields; Peter A Shapiro
Journal:  Psychosomatics       Date:  2020-06-12       Impact factor: 2.386

9.  Behavioral and Psychological Symptoms Impact Clinical Competence in Alzheimer's Disease.

Authors:  Elodie Bertrand; Eelco van Duinkerken; J Landeira-Fernandez; Marcia C N Dourado; Raquel L Santos; Jerson Laks; Daniel C Mograbi
Journal:  Front Aging Neurosci       Date:  2017-06-16       Impact factor: 5.750

10.  Psychiatric patients awareness of their illnesses and medications.

Authors:  Abdullah M Al Hathloul; Mohammad A Al Jafer; Ibrahim A Al Fraih
Journal:  Neurosciences (Riyadh)       Date:  2016-01       Impact factor: 0.735

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.